FTC's Pharma Patent Regulations Upheld
A D.C. federal judge on Friday sided with the Federal Trade Commission in a dispute over whether it was allowed to require drugmakers to report more exclusive patent licenses for approval...To view the full article, register now.
Already a subscriber? Click here to view full article